baber/WOPTO huggingface dataset:
Patent DD-300199-A7 (DD)
Title: Quantitatives Verfahren zur Bestimmung der Aufrauhhomogenität elektrochemisch aufgerauhter Aluminiumoberflächen
Inventor: LUEDERS ANDREAS DIPL PHYS
IPC: G01B21/30
Filed: 1989-09-13
Abstract: Die Erfindung betrifft ein quantitatives Verfahren zur Bestimmung der Aufrauhhomogenitaet elektrochemisch aufgerauhter Aluminiumoberflaechen. Sie beinhaltet das Gebiet der Oberflaechentechnik, insbesondere die elektrochemische Aufrauhung von Aluminium, die fuer dekorative und/oder funktionelle Zwecke, hauptsaechlich aber zur Herstellung von Traegermaterialien fuer Offsetdruckplatten verwendet wird. Die Erfindung ermoeglicht es, unter Zuhilfenahme des Tastschnittverfahrens quantitative Angaben zur Homogenitaet der Aufrauhstruktur elektrochemisch aufgerauhter Aluminiumoberflaechen zu machen. Diese Daten sind geeignet, in Korrelation zu den Herstellungsparametern sowie den dekorativen und/oder funktionellen Gebrauchseigenschaften der aufgerauhten Oberflaeche gesetzt zu werden. Erfindungsgemaesz wird die Makrostruktur der aufgerauhten Oberflaeche mit dem Variationskoeffizienten VSk der Schiefe Sk der Amplitudendichteverteilung ADK eines Tastschnittprofiles beschrieben. Zur Bestimmung der Homogenitaet der Aufrauhstruktur werden VSk und der Betrag von Sk, der die Mikrostruktur beschreibt, angegeben. Eine ideale Homogenitaet wird bei VSk0 und Sk0 definiert.{Oberflaechentechnik; Aufrauhung; Offsetdruckplatten; Aluminium; Homogenitaet; Tastschnittverfahren; Schiefe; Amplitudendichteverteilung; Makrostruktur; Mikrostruktur}
Patent WO-03042481-A8 (WO)
Title: Ensemble fenetre et procede de fabrication
Inventor: EDVARDSEN ALLAN
IPC: E04D13/035
Filed: 2002-11-12
Abstract: La présente invention concerne un ensemble fenêtre et le procédé de fabrication correspondant. L'ensemble est constitué d'un châssis de fenêtre et d'un battant correspondant. Le châssis est constitué de plusieurs profilés (120), le battant étant également constitué de plusieurs profilés (130). En l'occurrence, l'un au moins des profilés du châssis comprend, de même qu'un profilé du battant, au moins un élément en lamelle (100). De telles lamelles, qu'elles appartiennent au châssis ou au battant, présentent une section en coupe sensiblement identique. L'un au moins des profilés du châssis ou du battant comprend au moins deux éléments en lamelle, chacun des profilés du battant comprenant au moins un élément en lamelle.
Patent WO-0160530-A8 (WO)
Title: Appareil comportant un transducteur electro-acoustique formant des moyens de reproduction sonore et une partie des moyens generateurs de vibrations
Inventor: RUBERL ERNST
IPC: H04R13/00
Filed: 2001-01-31
Abstract: L'invention concerne un appareil (1) présentant un transducteur électro-acoustique (12) comprenant un système magnétique (13) utilisé pour réaliser des moyens générateurs de vibrations (35), caractérisé en ce que lesdits moyens générateurs de vibrations (15) comprennent, en plus du système magnétique (13), au moins une bobine génératrice de vibrations (36, 37) montée mobile, agencée dans la zone de champ parasite du système magnétique (13), et en ce que la bobine génératrice de vibrations (36, 37) est, de préférence, également connectée à une pièce métallique (38) en un matériau magnétique doux.
Patent WO-03106032-A8 (WO)
Title: Hybridization chamber
Inventor: MUELLER RALPH
IPC: B01L3/00
Filed: 2003-06-13
Abstract: The hybridization chamber has a base (10) with a recess (14) for accommodating a microarray (16). The chamber also comprises a cover (12), which can be placed onto the base (10) thereby resulting in the formation of a hermetically sealed space for the microarray. A covering surface (18) is provided on the cover (12) and is situated at a distance of approximately 20 ñm from the microarray while running parallel thereto. This enables a sample solution (38) to be drawn into the space between the microarray and the covering surface by means of capillary forces and to spread out evenly without requiring any pumps. The hybridization chamber makes it possible to work with minimal sample amounts without any dead space.
Patent WO-03046638-A8 (WO)
Title: Commutateur optique diffractif
Inventor: PFEIFFER PIERRE
IPC: G02B26/08
Filed: 2001-11-28
Abstract: La présente invention concerne un commutateur conçu pour orienter sélectivement un signal potique provenant d'un élément d'entrée vers un élément de sortie, caractérisé par le fait qu'il comprend un élément optique diffractif (100) apte à recevoir un faisceau optique en entrée et délivrer le faisceau en sortie selon une direction qui dépend du point d'impact du faisceau d'entrée sur cet élément optique diffractif et un moyen (200) apte à déplacer l'élément optique diffractif (100) transversalement au faisceau optique d'entrée entre au moins deux positions distantes.
Patent WO-9964626-A8 (WO)
Title: Sondes permettant de determiner un profil genetique
Inventor: ROBERTS GARETH WYN
IPC: C12Q1/68
Filed: 1999-06-04
Abstract: Il a été prouvé qu'un facteur important dont dépendent les différentes réactions individuelles à la maladie, à la thérapie et au pronostic, consiste en la configuration génétique d'une personne. De nombreux exemples démontrent que les polymorphismes d'un gène donné peuvent modifier la fonctionnalité de la protéine codée par ce gène, ce qui provoque une réaction physiologique variable. Dans le but d'intégrer la génomique à la pratique médicale, de concevoir et de construire une plate-forme technologique qui permettra la mise en application quotidienne de la médecine moléculaire, il est nécessaire de mettre sur pied un mode d'alignement des données des séquences d'ADN sur l'identification de gènes jouant un rôle primordial dans l'apparition, le développement, la progression et l'issue d'une maladie ou d'états physiologiques déterminés. D'après l'invention, le nombre de gènes et leurs configurations (mutations et polymorphismes) qu'il était indispensable d'identifier, de manière à obtenir des informations cliniques critiques concernant le pronostic individuel, est considérablement inférieur aux 100.000 gènes censés composer le génome humain. L'identification de l'identité du groupe central des gènes rend possible l'invention d'un modèle convenant à des procédures de définition des rprofils génétiques.
Patent WO-2004036868-A8 (WO)
Inventor: VAN DER VLEUTEN RENATUS J
IPC: H04N5/00
Filed: 2003-09-22
Abstract: A method and apparatus for delivering content to a user are disclosed. A data bit-stream is provided having a base layer data bit-stream and at least one enhancement layer data bit-stream. The data bit-streams are stored separately in a storage device. The stored content is then offered at different quality levels. When a request is received from the user for the content at a specified quality level, the base layer data bit-stream and however many enhancement layer data bit-streams that are needed to produce the specified quality level are downloaded to the user.
Patent WO-0078589-A8 (WO)
Title: Dispositif de transport de kayak
Inventor: CAPOBIANCO BENEDETTO S
IPC: B62B5/00
Filed: 2000-03-04
Abstract: L'invention concerne un dispositif (10) de transport de kayak servant à transporter un kayak, le kayak (12) présentant une coque munie d'une paire d'ouvertures (14a et 14b) pour monter le kayak (12) sur le dispositif (10) de transport de kayak. Le dispositif (10) de transport de kayak comprend un cadre (20) de transport sensiblement en forme de H comportant des premier et second éléments de cadre verticaux. Chacun des premier et second éléments de cadre verticaux possède une barre transversale (62) à laquelle il est relié, les barres transversales (62) pouvant être ajustées les unes par rapport aux autres afin d'ajuster l'espacement du cadre (20) de transport en forme de H de sorte qu'il corresponde à la distance existant entre chaque ouverture (14a et 14b) se trouvant sur la coque. Les premier et second éléments de cadre verticaux comprennent des premier et second éléments mâts supérieurs, lesquels possédant respectivement des extrémités de mât supérieures pouvant être insérées dans chaque ouverture de la coque du kayak afin de monté le kayak sur le dispositif de transport. Les premier et second éléments de cadre verticaux comprennent également des éléments de mât inférieurs respectifs, et un élément roue relié à chacun des éléments de mât inférieurs.
Patent WO-2004032331-A8 (WO)
Inventor: ZHAO LIXIN
IPC: H03M1/74
Filed: 2003-09-29
Abstract: A digital to analog converter (DAC) for a communications system with reduced intersymbol interference incorporates dynamic element matching (DEM) with a matching element array (12) having 2M bits for an input (10) corresponding to M+1 levels thereby employing only one half the range of the DEM and array to produce the DAC output (16).
Patent WO-2004059388-A8 (WO)
Title: Mesure generale de l'exposition a des medias d'affichage
Inventor: ZHANG JACK K
IPC: G06Q30/02
Filed: 2003-12-16
Abstract: L'invention concerne des systèmes, des procédés et des dispositifs permettant de rassembler des données concernant l'exposition de personnes sondées prédéterminées à des données de médias et à des panneaux publicitaires. L'invention concerne notamment un appareil portatif de contrôle de l'exposition à des données de médias et à des panneaux publicitaires, destiné à être porté par une personne sondée. Cet appareil de contrôle comprend un moyen d'exposition à des panneaux publicitaires servant à produire des données de contrôle de l'exposition à des panneaux publicitaires, un appareil de contrôle de l'exposition à des données de médias, ainsi qu'un boîtier contenant ledit moyen et ledit appareil.
Patent WO-9946367-A8 (WO)
Title: Techniques de diagnostic et de tri avec utilisation de mesures d'activation cellulaire
Inventor: STOUGHTON ROLAND B
IPC: A61P25/28
Filed: 1999-03-11
Abstract: La présente invention concerne des techniques de diagnostic faisant intervenir au moins un essai de confirmation de l'activation cellulaire. Ces essais sont menés sur le sang total ou les leucocytes, et plus particulièrement les neutrophiles. En outre, ces essais indiquent individuellement ou combinés à d'autres le niveau d'activation cellulaire cardio-vasculaire qui est un indicateur clé de nombreux états pathologiques chroniques ou aigus. On utilise les résultats de ces essais dans un cadre clinique pour venir en appui de décisions thérapeutiques telles que la poursuite de la recherche d'agents infectieux, les thérapies antioxydants ou anti-adhésion, le report et la reprogrammation optimale des interventions chirurgicales à haut risque, la classification de la susceptibilité d'affections chroniques (et de leur taux de progression) telles que le diabète, le rejet d'organe, l'athérogénèse et les insuffisances veineuses interventions extrêmes en traumatologie à haut risque et thérapies à abaissement de l'activation. L'invention concerne également une composition dérivée d'un homogénat pancréatique qui contient des facteurs d'activation de cellules circulantes, et qui peut servir de cibles pour la recherche systématique de médicaments de façon à identifier les candidats médicaments à utiliser pour les thérapies d'abaissement de l'activation. L'invention concerne en outre des techniques d'abaissement de l'activation cellulaire consistant à administrer des inhibiteurs de protéases, et notamment des inhibiteurs de protéines sériques. L'invention concerne enfin des nécessaires pour la mise en oeuvre de ces techniques.
Patent WO-0009658-A8 (WO)
Title: Gene regulating circadian clock function and photoperiodism
Inventor: WAGNER RY
IPC: C07H21/02
Filed: 1999-08-17
Abstract: Nucleic acid molecules that encode plant proteins involved in photoperiodism and circadian rhythms are disclosed. These molecules may be introduced into plants in order to alter the photoperiodic and/or circadian clock-based gene expression of the plants.
Patent WO-0021550-A8 (WO)
Inventor: TSAI LI-HUEI
IPC: A61K31/445
Filed: 1999-10-13
Abstract: The present invention relates to methods of preventing or treating neurodegenerative diseases by administering an antagonist or inhibitor of p25. In particular, the invention relates to methods of preventing or treating a neurodegenerative disease by administering a calpain antagonist or inhibitor, or a cation antagonist or inhibitor, which reduces the truncation or conversion of p35 to p25. It also relates to p.35 and antibodies directed to p.25 and cdk 5. It relates to methods of inhibiting p25/cdk association, cdk 5 deregulation and phosphorylation of tan. Methods of assessing neurodegeneratives diseases using p 25 are provided.
Patent EP-1157652-A8 (EP)
Inventor: POLTI FRANCO
IPC: A47L9/28
Filed: 2000-05-23
Abstract: A machine for cleaning (1) comprising a body (2)
that contains a tank (5) for a liquid (6) and suction
means (16, 17) contained inside body (2) in fluid
communication with the said tank (5) via a suction path
(15, 18, 26) is characterized in that it includes means
(19, 20) for detecting presence of the said liquid (6)
downstream from the said tank (5), the said detecting
means (19, 20) being connected operationally to the
suction means (16, 17) for stopping the suction upon
detection of the presence of the said liquid (6).
Patent EP-2460755-A8 (EP)
Inventor: THIELOW FRANK W
IPC: B66B5/00
Filed: 2009-07-22
Abstract: The device has a drive unit comprising a drive element that consists of drive motors (14) and a drive shaft (11). A gear reduction unit i.e. traction unit drive, has bearing units (4) for bearing of an output shaft (3), where the bearing units are arranged on both sides of output elements i.e. traction sheaves (20). A supporting device i.e. screw (30) is provided for supporting of the drive shaft and/or output shafts between two bearing devices i.e. support bearing (12) of the drive unit and/or between the two bearing units of the gear reduction unit, during mounting and demounting phase. An independent claim is also included for a method for mounting or demounting or maintaining a lifting device.
Patent BR-PI0503479-A8 (BR)
Title: Lipossomas ph-sensíveis para transporte de ácidos nucléicos e seu processo de obtenção
Inventor: Mônica Cristina De Oliveira
IPC: A61K48/00
Filed: 2005-07-27
Abstract: LIPOSSOMAS PH-SENSÍVEIS PARA TRANSPORTE DE ÁCIDOS NUCLÉICOS E SEU PROCESSO DE OBTENÇÃO. Esse sistema de transporte de ácidos nucléicos apresenta uma elevada taxa de encapsulação, homogeneidade de diâmetro das vesículas e podem permitir uma eficaz expressão gênica, inibição da transcrição e/ou tradução, além de reduzida ou ausência de citotoxicidade. Os lipossomas pH-sensíveis são constituídos por complexo de ciclodextrina catiônica/ácidos nucléicos, fosfolípes formadores de fases não lamelares ou misturas de lamelares e não lamelares, compostos estabilizadores contendo grupamentos aniônicos juntamente ou não com fosfolípide acoplado à cadeia de polietilenoglicol.
Patent BR-PI0805534-A8 (BR)
Title: subconjunto de freio e formação de retenção
Inventor: FRANZ HELMUT HOLL
IPC: F16D65/14
Filed: 2008-12-24
Abstract: formação de retenção. a presente invenção refere-se a uma formação de retenção definida em uma alavanca de freio de um freio a disco a ar, que compreende uma conexão de ajuste de empurrar/encaixe com pressão para a fixação de forma liberável de uma biela a uma alavanca de freio. uma formação de re- tenção para retenção de uma biela em uma alavanca de freio, a formação compreendendo uma conexão com pino e uma junta de esfera e de soquete, em que um eixo geométrico principal da conexão com pino é coincidente com um centro de rotação da junta de esfera e de soquete. uma formação de retenção para retenção de uma biela em uma alavanca de freio, a formação compreendendo uma formação côncava em uma dentre a biela e a alavanca de freio e uma formação convexa correspondente na outra dentre a biela e a alavanca de freio, em que a formação côncava circunda pelo menos parcialmente a formação convexa, para se evitar uma separação axial da biela e da alavanca de freio. um método de montagem de um subconjunto de freio que compreende as etapas de: provisão de uma biela, provisão de uma alavanca de freio que compreende uma formação de retenção conforme acima, montagem da biela e da alavanca de freio de modo que pelo menos uma porção da formação de retenção se deforme durante a montagem e salte para trás quando a biela for montada na alavanca de freio, para a provisão de uma conexão de encaixe com pressão entre elas. um método de fabricação de uma formação de retenção conforme acima, que compreende as etapas de: provisão de uma biela e de uma alavanca de freio com uma formação côncava, provisão da outra dentre a biela e a alavanca de freio com uma formação convexa capaz de receber a formação côncava, montagem da formação côncava e convexa, trabalho mecânico em uma dentre a biela e a alavanca de freio com a formação côncava, de modo que a formação côncava circunde pelo menos parcialmente a formação convexa, para se evitar uma separação axial da biela e da alavanca de freio.
Patent BR-PI0907854-A8 (BR)
Title: Uso de derivados de ácido tetrâmico para o combate de parasitas animais após tratamentos de tronco, ramos, inflorescências e brotos
Inventor: REINER FISCHER
IPC: A01P7/02
Filed: 2009-02-06
Abstract: USO DE DERIVADOS DE ÁCIDO TETRÂMICO PARA O COMBATE DE PARASITAS ANIMAIS APÓS TRATAMENTOS DE TRONCO, RAMOS, INFLORESCÊNCIAS E BROTOS. A presente invenção refere-se ao uso de derivados de ácido tetrâmico das fórmulas (I) ou (II) para o combate de parasitas animais após tratamentos de tronco (pulverização, pintura, injeção, aplicação), tratamentos de galhos, caules, rebentos e ramos (pintura, pulverização, aplicação), tratamentos de inflorescências e botões através de injeção.
Patent GB-2600638-A8 (GB)
Title: System and method for real time control of an autonomous device
Inventor: DIRK A VAN DER MERWE
IPC: G01S17/89
Filed: 2020-07-10
Abstract: An autonomous vehicle having sensors advantageously varied in capabilities, advantageously positioned, and advantageously impervious to environmental conditions. A system executing on the autonomous vehicle that can receive a map including, for example, substantially discontinuous surface features along with data from the sensors, create an occupancy grid based upon the map and the data, and change the configuration of the autonomous vehicle based upon the type of surface on which the autonomous vehicle navigates. The device can safely navigate surfaces and surface features, including traversing discontinuous surfaces and other obstacles.
Patent GB-2612278-A8 (GB)
Title: Property lead finder systems and methods of its use
Inventor: Pooyan Asgari
IPC: G06Q30/06
Filed: 2021-08-09
Abstract: A property lead finder system for determining a property lead, comprising: a transceiving module configured to receive clickstream data from at least one data source, wherein the clickstream data comprising property data, wealth properties history available within the at least one data source and user interaction data based on an interaction of a plurality of users with the at least one data source; a prediction module configured to: map the received clickstream data to a propensity to sell one or more lead properties at a level of a physical property address; determine a propensity data comprising a property address of the one or more lead properties and a score indicating the propensity to sell the one or more lead properties based on the mapping; and match the propensity data against a third-party database to determine at least one lead property for creating an output list of property addresses for at least one third-party, wherein the output list of property addresses comprises property information of at least one lead property that is common in the one or more lead properties and the third-party's database and a flag indicating the propensity to sell the at least one lead property.
Patent RO-127665-A8 (RO)
Title: Device for applying surface treatment products on warp threads
Inventor: VISILEANU EMILIA
IPC: D04B23/16
Filed: 2010-12-20
Abstract: The invention relates to a device, attached to the warping machine, for applying surface treatment products on warp threads. According to the invention, the device comprises a tank (2) for storing the treating solution wherefrom the solution is supplied by a pump (3) into a vat (1) wherefrom a cylinder (8), being rotated clockwise by a geared electric motor (12) and by a gear with wheels and a transmission belt (13, 14, 15), carries it along on the threads which form the band of warp threads and which are directed under a roller (10) for adjusting the coating, between the scraping roller (9) and the cylinder (8), and under the roller (11) for positioning the band to be treated, the adjustment of the substance quantity to be applied being carried out either by displacing the roller (10), or by increasing the peripheral speed of the cylinder (8) by increasing the speed of the motor (12).
Patent AU-2003265832-A8 (AU)
Title: Methods of screening for compounds that modulate tafia activity, compounds, and methods of using the compounds
Inventor: TRIFONOV LATCHEZAR
IPC: G01N33/68
Filed: 2003-08-29
Abstract: Provided are methods of screening compounds for any aspirin-related activity other than TAFI inhibition, and also for non-inhibition of TAFI. Compounds identified by the screening methods can be used to treat, prevent or manage in a patient pain, fever, colon cancer, pancreatic cancer or an inflammatory, platelet aggregation, fibrinolytic or hemorrhagic disease or disorder. Also provided is a method of evaluating test compounds for TAFI inhibitory activity wherein the TAFI inhibitory activity of these test compounds is compared to the TAFI inhibitory activity of aspirin or its derivatives or metabolites. Further provided is a method of treating, preventing or managing in a patient, a hemorrhagic or thrombotic disease or disorder with high dose aspirin or aspirin derivatives or metabolites. Also contemplated is a method of treating, preventing or managing in a patient, pain, fever, colon cancer, pancreatic cancer or an inflammatory, platelet aggregation, fibrinolytic or hemorrhagic disease or disorder comprising administering aspirin or a derivative thereof or any other therapeutic having at least one desired therapeutic or prophylactic activity of aspirin to a patient in need thereof and administering to the patient a factor that promotes TAFIa activity, e.g. stabilized TAFIa, to ameliorate one or more adverse side effects of the therapeutic. Compounds identified by the methods of the invention are also provided.
Patent AU-2011271043-A8 (AU)
Title: Mice expressing a light chain with human lambda variable and mouse constant regions
Inventor: MACDONALD LYNN
IPC: C07K16/00
Filed: 2011-06-22
Abstract: Genetically modified mice are provided that express human λ variable (hVλ) sequences, including mice that express hVλ sequences from an endogenous mouse λ light chain locus, mice that express hVλ sequences from an endogenous mouse κ light chain locus, and mice that express hVλ sequences from a transgene or an episome wherein the hVλ sequence is linked to a mouse constant sequence. Mice are provided that are a source of somatically mutated human λ variable sequences useful for making antigen- binding proteins. Compositions and methods for making antigen-binding proteins that comprise human λ variable sequences, including human antibodies, are provided.